Journals
Publish with us
Publishing partnerships
About us
Blog
Oxidative Medicine and Cellular Longevity
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Oxidative Medicine and Cellular Longevity
/
2022
/
Article
/
Tab 3
/
Research Article
[Retracted] Clinical Efficacy of PEG-IFN
α
-2a and PEG-IFN
α
-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study
Table 3
Comparison of marker conversion [
].
Group 2a (
)
Group 2b (
)
HBV-DNA negative conversion rate
T1
8 (19.05)
13 (30.95)
1.587
0.208
T2
24 (57.14)
25 (59.52)
0.049
0.825
T3
34 (80.95)
36 (85.71)
0.343
0.558
HBsAg negative conversion rate
T1
1 (2.38)
2 (4.76)
0.346
0.557
T2
3 (7.14)
4 (9.52)
0.156
0.693
T3
5 (11.90)
5 (11.90)
—
—
HBeAg negative conversion rate
T1
8 (19.05)
10 (23.81)
0.283
0.595
T2
14 (33.33)
15 (35.71)
0.053
0.819
T3
22 (52.38)
24 (57.14)
0.192
0.661